Abstract
Long non-coding RNA (lncRNA) Xist has emerged as a key modulator in dosage compensation by randomly inactivating one of the X chromosomes in mammals during embryonic development. Dysregulation of X chromosome inactivation (XCI) due to deletion of Xist has been proven to induce hematologic cancer in mice. However, this phenomenon is not consistent in humans as growing evidence suggests Xist can suppress or promote cancer growth in different organs of the human body. In this review, we discuss recent advances of XCI in human embryonic stem cells and provide an explanation for the seemingly contradictory roles of Xist in development of human cancer.
| Original language | English |
|---|---|
| Pages (from-to) | 314-323 |
| Number of pages | 10 |
| Journal | Stem Cell Reviews and Reports |
| Volume | 15 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Apr 15 2019 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cancer stem cell
- Competing endogenous RNA
- Exosomes
- Long non-coding RNA
- MicroRNAs
- X Chromosome inactivation
- XACT non-coding RNA
- XIST non-coding RNA
ASJC Scopus subject areas
- Cell Biology
- Cancer Research
Fingerprint
Dive into the research topics of 'The Ambivalent Role of lncRNA Xist in Carcinogenesis'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS